1
|
Neumann S, Bauer CM, Nastasi L, Läderach J, Thürlimann E, Schwarz A, Held JPO, Easthope CA. Accuracy, concurrent validity, and test-retest reliability of pressure-based insoles for gait measurement in chronic stroke patients. Front Digit Health 2024; 6:1359771. [PMID: 38633383 PMCID: PMC11021704 DOI: 10.3389/fdgth.2024.1359771] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/21/2023] [Accepted: 03/11/2024] [Indexed: 04/19/2024] Open
Abstract
Introduction Wearables are potentially valuable tools for understanding mobility behavior in individuals with neurological disorders and how it changes depending on health status, such as after rehabilitation. However, the accurate detection of gait events, which are crucial for the evaluation of gait performance and quality, is challenging due to highly individual-specific patterns that also vary greatly in movement and speed, especially after stroke. Therefore, the purpose of this study was to assess the accuracy, concurrent validity, and test-retest reliability of a commercially available insole system in the detection of gait events and the calculation of stance duration in individuals with chronic stroke. Methods Pressure insole data were collected from 17 individuals with chronic stroke during two measurement blocks, each comprising three 10-min walking tests conducted in a clinical setting. The gait assessments were recorded with a video camera that served as a ground truth, and pressure insoles as an experimental system. We compared the number of gait events and stance durations between systems. Results and discussion Over all 3,820 gait events, 90.86% were correctly identified by the insole system. Recall values ranged from 0.994 to 1, with a precision of 1 for all measurements. The F1 score ranged from 0.997 to 1. Excellent absolute agreement (Intraclass correlation coefficient, ICC = 0.874) was observed for the calculation of the stance duration, with a slightly longer stance duration recorded by the insole system (difference of -0.01 s). Bland-Altmann analysis indicated limits of agreement of 0.33 s that were robust to changes in walking speed. This consistency makes the system well-suited for individuals post-stroke. The test-retest reliability between measurement timepoints T1 and T2 was excellent (ICC = 0.928). The mean difference in stance duration between T1 and T2 was 0.03 s. We conclude that the insole system is valid for use in a clinical setting to quantitatively assess continuous walking in individuals with stroke.
Collapse
Affiliation(s)
- Saskia Neumann
- DART, Lake Lucerne Institute, Vitznau, Switzerland
- Cereneo Foundation, Vitznau, Switzerland
| | | | - Luca Nastasi
- DART, Lake Lucerne Institute, Vitznau, Switzerland
- Cereneo Foundation, Vitznau, Switzerland
| | | | - Eva Thürlimann
- Vascular Neurology and Neurorehabilitation, University of Zurich, Zurich, Switzerland
| | - Anne Schwarz
- Vascular Neurology and Neurorehabilitation, University of Zurich, Zurich, Switzerland
| | - Jeremia P. O. Held
- Vascular Neurology and Neurorehabilitation, University of Zurich, Zurich, Switzerland
| | - Chris A. Easthope
- DART, Lake Lucerne Institute, Vitznau, Switzerland
- Cereneo Foundation, Vitznau, Switzerland
| |
Collapse
|
2
|
Moreau C, Rouaud T, Grabli D, Benatru I, Remy P, Marques AR, Drapier S, Mariani LL, Roze E, Devos D, Dupont G, Bereau M, Fabbri M. Overview on wearable sensors for the management of Parkinson's disease. NPJ Parkinsons Dis 2023; 9:153. [PMID: 37919332 PMCID: PMC10622581 DOI: 10.1038/s41531-023-00585-y] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/25/2023] [Accepted: 10/02/2023] [Indexed: 11/04/2023] Open
Abstract
Parkinson's disease (PD) is affecting about 1.2 million patients in Europe with a prevalence that is expected to have an exponential increment, in the next decades. This epidemiological evolution will be challenged by the low number of neurologists able to deliver expert care for PD. As PD is better recognized, there is an increasing demand from patients for rigorous control of their symptoms and for therapeutic education. In addition, the highly variable nature of symtoms between patients and the fluctuations within the same patient requires innovative tools to help doctors and patients monitor the disease in their usual living environment and adapt treatment in a more relevant way. Nowadays, there are various body-worn sensors (BWS) proposed to monitor parkinsonian clinical features, such as motor fluctuations, dyskinesia, tremor, bradykinesia, freezing of gait (FoG) or gait disturbances. BWS have been used as add-on tool for patients' management or research purpose. Here, we propose a practical anthology, summarizing the characteristics of the most used BWS for PD patients in Europe, focusing on their role as tools to improve treatment management. Consideration regarding the use of technology to monitor non-motor features is also included. BWS obviously offer new opportunities for improving management strategy in PD but their precise scope of use in daily routine care should be clarified.
Collapse
Affiliation(s)
- Caroline Moreau
- Department of Neurology, Parkinson's disease expert Center, Lille University, INSERM UMRS_1172, University Hospital Center, Lille, France
- The French Ns-Park Network, Paris, France
| | - Tiphaine Rouaud
- The French Ns-Park Network, Paris, France
- CHU Nantes, Centre Expert Parkinson, Department of Neurology, Nantes, F-44093, France
| | - David Grabli
- The French Ns-Park Network, Paris, France
- Assistance Publique Hôpitaux de Paris, Department of Neurology, CIC Neurosciences, Pitié-Salpêtrière Hospital, Sorbonne University, Paris, France
- Sorbonne University, Paris Brain Institute - ICM, Inserm, CNRS, Paris, France
| | - Isabelle Benatru
- The French Ns-Park Network, Paris, France
- Department of Neurology, University Hospital of Poitiers, Poitiers, France
- INSERM, CHU de Poitiers, University of Poitiers, Centre d'Investigation Clinique CIC1402, Poitiers, France
| | - Philippe Remy
- The French Ns-Park Network, Paris, France
- Centre Expert Parkinson, NS-Park/FCRIN Network, CHU Henri Mondor, AP-HP, Equipe NPI, IMRB, INSERM et Faculté de Santé UPE-C, Créteil, FranceService de neurologie, hôpital Henri-Mondor, AP-HP, Créteil, France
| | - Ana-Raquel Marques
- The French Ns-Park Network, Paris, France
- Université Clermont Auvergne, CNRS, Clermont Auvergne INP, Institut Pascal, Clermont-Ferrand University Hospital, Neurology department, Clermont-Ferrand, France
| | - Sophie Drapier
- The French Ns-Park Network, Paris, France
- Pontchaillou University Hospital, Department of Neurology, CIC INSERM 1414, Rennes, France
| | - Louise-Laure Mariani
- The French Ns-Park Network, Paris, France
- Assistance Publique Hôpitaux de Paris, Department of Neurology, CIC Neurosciences, Pitié-Salpêtrière Hospital, Sorbonne University, Paris, France
- Sorbonne University, Paris Brain Institute - ICM, Inserm, CNRS, Paris, France
| | - Emmanuel Roze
- The French Ns-Park Network, Paris, France
- Assistance Publique Hôpitaux de Paris, Department of Neurology, CIC Neurosciences, Pitié-Salpêtrière Hospital, Sorbonne University, Paris, France
- Sorbonne University, Paris Brain Institute - ICM, Inserm, CNRS, Paris, France
| | - David Devos
- The French Ns-Park Network, Paris, France
- Parkinson's Disease Centre of Excellence, Department of Medical Pharmacology, Univ. Lille, INSERM; CHU Lille, U1172 - Degenerative & Vascular Cognitive Disorders, LICEND, NS-Park Network, F-59000, Lille, France
| | - Gwendoline Dupont
- The French Ns-Park Network, Paris, France
- Centre hospitalier universitaire François Mitterrand, Département de Neurologie, Université de Bourgogne, Dijon, France
| | - Matthieu Bereau
- The French Ns-Park Network, Paris, France
- Service de neurologie, université de Franche-Comté, CHRU de Besançon, 25030, Besançon, France
| | - Margherita Fabbri
- The French Ns-Park Network, Paris, France.
- Department of Neurosciences, Clinical Investigation Center CIC 1436, Parkinson Toulouse Expert Centre, NS-Park/FCRIN Network and NeuroToul COEN Center, Toulouse University Hospital, INSERM, University of Toulouse 3, Toulouse, France.
| |
Collapse
|
3
|
Siebert S, Pennington SR, Raychaudhuri SP, Chaudhari AJ, Jin JQ, Liao W, Chandran V, FitzGerald O. Novel Insights From Basic Science in Psoriatic Disease at the GRAPPA 2022 Annual Meeting. J Rheumatol 2023; 50:66-70. [PMID: 37527860 DOI: 10.3899/jrheum.2023-0535] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 05/30/2023] [Indexed: 08/03/2023]
Abstract
Recent basic science advances in psoriatic disease (PsD) were presented and discussed at the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA) 2022 annual meeting. Topics included clinical applications of biomarkers, what the future of biomarkers for PsD may hold, the challenges of developing biomarker research to the point of clinical utility, advances in total-body positron emission tomography/computed tomography imaging, and emerging concepts from single-cell studies in PsD.
Collapse
Affiliation(s)
- Stefan Siebert
- S. Siebert, MD, PhD, School of Infection and Immunity, University of Glasgow, Glasgow, UK
| | - Stephen R Pennington
- S.R. Pennington, PhD, O. FitzGerald, MD, School of Medicine, UCD Conway Institute for Biomolecular Research, University College Dublin, Dublin, Ireland
| | - Siba P Raychaudhuri
- S.P. Raychaudhuri, MD, Department of Internal Medicine-Rheumatology, UC Davis School of Medicine and Northern California Veterans Affairs Medical Center, Mather, California, USA
| | - Abhijit J Chaudhari
- A.J. Chaudhari, PhD, Department of Radiology, UC Davis School of Medicine, Sacramento, California, USA
| | - Joy Q Jin
- J.Q. Jin, AB, School of Medicine, and Department of Dermatology, University of California San Francisco, San Francisco, California, USA
| | - Wilson Liao
- W. Liao, MD, Department of Dermatology, University of California San Francisco, San Francisco, California, USA
| | - Vinod Chandran
- V. Chandran, DM, PhD, Departments of Medicine, Laboratory Medicine, and Pathobiology and Institute of Medical Science, University of Toronto, and Schroeder Arthritis Institute, Krembil Research Institute, University Health Network, Toronto, Ontario, Canada
| | - Oliver FitzGerald
- S.R. Pennington, PhD, O. FitzGerald, MD, School of Medicine, UCD Conway Institute for Biomolecular Research, University College Dublin, Dublin, Ireland;
| |
Collapse
|
4
|
Mostovov A, Jacobs D, Farid L, Dhellin P, Baille G. Test-retest reliability of the six-minute walking distance measurements using FeetMe insoles by completely unassisted healthy adults in their homes. PLOS DIGITAL HEALTH 2023; 2:e0000262. [PMID: 37992015 PMCID: PMC10664940 DOI: 10.1371/journal.pdig.0000262] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 05/03/2023] [Accepted: 10/16/2023] [Indexed: 11/24/2023]
Abstract
Wearable technology provides an opportunity for new ways of monitoring patient gait remotely, through at-home self-administered six-minute walk tests (6MWTs). The purpose of this study was to evaluate the test-retest reliability of FeetMe insoles, a wearable gait assessment device, for measuring the six-minute walking distance (6MWD) during tests conducted with a one-week interval by completely unassisted healthy adults in their homes. Participants (n = 21) performed two 6MWTs at home while wearing the FeetMe insoles, and two 6MWTs at hospital while wearing FeetMe insoles and being assessed by a rater. All assessments were performed with a one-week interval between tests, no assistance was provided to the participants at home. The agreement between the 6MWD measurements made at baseline and at Week 1 was good for all test configurations and was highest for the at-home FeetMe measurements, with an intraclass correlation coefficient (ICC) of 0.95, standard error of the measurement (SEM) of 15.02 m and coefficient of variation (CV) of 3.33%, compared to ICCs of 0.79 and 0.78, SEMs of 25.65 and 26.65 and CVs of 6.24% and 6.10% for the rater and FeetMe measurements at hospital, respectively. Our work demonstrates that the FeetMe system could provide a reliable solution allowing individuals to self-administer 6MWTs independently at home.
Collapse
Affiliation(s)
| | | | - Leila Farid
- FeetMe SAS, 157 bd. MacDonald, Paris, France
| | | | - Guillaume Baille
- Neurology department, Delafontaine Hospital Center, Saint-Denis, France
| |
Collapse
|
5
|
Kromołowska K, Kluza K, Kańtoch E, Sulikowski P. Open-Source Strain Gauge System for Monitoring Pressure Distribution of Runner's Feet. SENSORS (BASEL, SWITZERLAND) 2023; 23:s23042323. [PMID: 36850921 PMCID: PMC9959378 DOI: 10.3390/s23042323] [Citation(s) in RCA: 1] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Received: 12/29/2022] [Revised: 02/10/2023] [Accepted: 02/16/2023] [Indexed: 06/12/2023]
Abstract
The objective of the research presented in this paper was to provide a novel open-source strain gauge system that shall enable the measurement of the pressure of a runner's feet on the ground and the presentation of the results of that measurement to the user. The system based on electronic shoe inserts with 16 built-in pressure sensors laminated in a transparent film was created, consisting of two parts: a mobile application and a wearable device. The developed system provides a number of advantages in comparison with existing solutions, including no need for calibration, an accurate and frequent measurement of pressure distribution, placement of electronics on the outside of a shoe, low cost, and an open-source approach to encourage enhancements and open collaboration.
Collapse
Affiliation(s)
- Klaudia Kromołowska
- AGH University of Science and Technology, al. A. Mickiewicza 30, 30-059 Krakow, Poland
- Faculty of Computer Science and Telecommunications, Cracow University of Technology, ul. Warszawska 24, 31-155 Kraków, Poland
| | - Krzysztof Kluza
- AGH University of Science and Technology, al. A. Mickiewicza 30, 30-059 Krakow, Poland
| | - Eliasz Kańtoch
- AGH University of Science and Technology, al. A. Mickiewicza 30, 30-059 Krakow, Poland
| | - Piotr Sulikowski
- Faculty of Computer Science and Information Technology, West Pomeranian University of Technology, ul. Żołnierska 49, 71-210 Szczecin, Poland
| |
Collapse
|
6
|
Granja Domínguez A, Romero Sevilla R, Alemán A, Durán C, Hochsprung A, Navarro G, Páramo C, Venegas A, Lladonosa A, Ayuso GI. Study for the validation of the FeetMe® integrated sensor insole system compared to GAITRite® system to assess gait characteristics in patients with multiple sclerosis. PLoS One 2023; 18:e0272596. [PMID: 36758111 PMCID: PMC9910712 DOI: 10.1371/journal.pone.0272596] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/28/2022] [Accepted: 07/23/2022] [Indexed: 02/11/2023] Open
Abstract
OBJECTIVE To determine the concordance and statistical precision in gait velocity in people with multiple sclerosis (pwMS), measured with FeetMe® (insoles with pressure and motion sensors) compared with GAITRite® (classic reference system of gait analysis) in the timed 25-Feet Walk test (T25WT). METHODS This observational, cross-sectional, prospective, single center study was conducted between September-2018 and April-2019 in pwMS aged 18-55 years, with Expanded Disability Status Scale (EDSS) 0-6.5 and relapse free ≥30 days at baseline. Primary endpoint was gait velocity. Secondary endpoints were ambulation time, cadence, and stride length assessment, while the correlation between gait variables and the clinical parameters of MS subjects was assessed as an exploratory endpoint. RESULTS A total of 207 MS subjects were enrolled, of whom, 205 were considered in primary analysis. Most subjects were women (66.8%) and had relapsing-remitting MS (RRMS) (82.9%), with overall mean (standard deviation [SD]) age of 41.5 (8.0) year and EDSS 3.1 (2.0). There was a statistically significant (p<0.0001) and strong agreement (intra-class correlation coefficient (ICC) >0.830) in gait velocity, ambulation time and cadence assessment between FeetMe® and GAITRite®. CONCLUSIONS Agreement between devices was strong (ICC≥0.800). FeetMe® is the first validated wearable medical device that allows gait monitoring in MS subjects, being potentially able to assess disease activity, progression, and treatment response.
Collapse
Affiliation(s)
- Anabel Granja Domínguez
- Departamento de Neurología, Fundación para el Desarrollo de la Investigación y Asistencia de Enfermedades Neurológicas y Afines Crónicas (DINAC), Castilleja de la Cuesta, Sevilla, Spain
- Departamento de Neurología, Hospital Vithas Nisa, Unidad de Investigación y Tratamiento de la Esclerosis Múltiple, Sevilla, Spain
| | | | - Aurora Alemán
- Departamento de Neurología, Fundación para el Desarrollo de la Investigación y Asistencia de Enfermedades Neurológicas y Afines Crónicas (DINAC), Castilleja de la Cuesta, Sevilla, Spain
- Departamento de Neurología, Hospital Vithas Nisa, Unidad de Investigación y Tratamiento de la Esclerosis Múltiple, Sevilla, Spain
| | - Carmen Durán
- Departamento de Neurología, Fundación para el Desarrollo de la Investigación y Asistencia de Enfermedades Neurológicas y Afines Crónicas (DINAC), Castilleja de la Cuesta, Sevilla, Spain
| | - Anja Hochsprung
- Departamento de Neurología, Fundación para el Desarrollo de la Investigación y Asistencia de Enfermedades Neurológicas y Afines Crónicas (DINAC), Castilleja de la Cuesta, Sevilla, Spain
| | - Guillermo Navarro
- Departamento de Neurología, Fundación para el Desarrollo de la Investigación y Asistencia de Enfermedades Neurológicas y Afines Crónicas (DINAC), Castilleja de la Cuesta, Sevilla, Spain
| | - Cristina Páramo
- Departamento de Neurología, Fundación para el Desarrollo de la Investigación y Asistencia de Enfermedades Neurológicas y Afines Crónicas (DINAC), Castilleja de la Cuesta, Sevilla, Spain
- Departamento de Neurología, Hospital Vithas Nisa, Unidad de Investigación y Tratamiento de la Esclerosis Múltiple, Sevilla, Spain
| | - Ana Venegas
- Departamento de Neurología, Fundación para el Desarrollo de la Investigación y Asistencia de Enfermedades Neurológicas y Afines Crónicas (DINAC), Castilleja de la Cuesta, Sevilla, Spain
- Departamento de Neurología, Hospital Vithas Nisa, Unidad de Investigación y Tratamiento de la Esclerosis Múltiple, Sevilla, Spain
| | - Ana Lladonosa
- Neurociencias, Novartis Farmacéutica, S.A., Barcelona, Spain
| | - Guillermo Izquierdo Ayuso
- Departamento de Neurología, Fundación para el Desarrollo de la Investigación y Asistencia de Enfermedades Neurológicas y Afines Crónicas (DINAC), Castilleja de la Cuesta, Sevilla, Spain
- Departamento de Neurología, Hospital Vithas Nisa, Unidad de Investigación y Tratamiento de la Esclerosis Múltiple, Sevilla, Spain
- * E-mail:
| |
Collapse
|
7
|
Wen ZF, Peng SH, Wang JL, Wang HY, Yang LP, Liu Q, Zhang XG. Prevalence of motoric cognitive risk syndrome among older adults: a systematic review and meta-analysis. Aging Ment Health 2022:1-13. [PMID: 36533320 DOI: 10.1080/13607863.2022.2158305] [Citation(s) in RCA: 2] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/23/2022]
Abstract
OBJECTIVE Motoric cognitive risk syndrome (MCR) is a newly proposed pre-dementia syndrome. Several studies on the prevalence of MCR have been published; however, the data vary across studies with different epidemiological characteristics. Thus, this study aimed to quantitatively analyse the overall prevalence and associated epidemiological characteristics of MCR among older adults aged ≥ 60 years. METHODS The Cochrane Library, PubMed, Web of Science, CINAHL, Embase, Scopus, PsycInfo, China National Knowledge Infrastructure, Weipu Database, China Biology Medicine disc and Wanfang Database were searched from their inception to January 2022. A modified Newcastle-Ottawa Scale evaluated the risk of bias. Statistical heterogeneity among the included studies was analysed using Cochran's Q and I2 tests. A random effect model calculated pooled prevalence owing to study heterogeneity. Begg's and Egger's tests were used to assess the publication bias. Additionally, subgroup analysis and meta-regression were performed based on different epidemiological characteristics to determine heterogeneity sources. RESULTS Sixty-two studies comprising 187,558 samples were obtained. The pooled MCR prevalence was 9.0% (95% confidence interval: 8.3-9.8). A higher MCR prevalence was observed in females, older adults with a low educational level, depression and cardiovascular risk factors, South American populations, and studies with small sample sizes and cross-section designs. Furthermore, subjective cognitive complaint using scale score and gait speed using instrument gait showed higher MCR prevalence. CONCLUSION MCR is common in older adults, and various epidemiological characteristics influence its prevalence. Thus, preventive measures are required for older adults with higher MCR prevalence.
Collapse
Affiliation(s)
- Zhi-Fei Wen
- School of Nursing, Chengdu university of Traditional Chinese Medicine, Sichuan, China
| | - Si-Han Peng
- School Clinical, Chengdu university of Traditional Chinese Medicine, Sichuan, China
| | - Jia-Lin Wang
- School of Nursing, Chengdu university of Traditional Chinese Medicine, Sichuan, China
| | - Hong-Yan Wang
- Dean Office, Sichuan Nursing Vocational College, Sichuan, China
| | - Li-Ping Yang
- School of Nursing, Chengdu university of Traditional Chinese Medicine, Sichuan, China
| | - Qin Liu
- School of Nursing, Chengdu university of Traditional Chinese Medicine, Sichuan, China
| | - Xian-Geng Zhang
- Dean Office, Sichuan Nursing Vocational College, Sichuan, China
| |
Collapse
|
8
|
Parati M, Gallotta M, Muletti M, Pirola A, Bellafà A, De Maria B, Ferrante S. Validation of Pressure-Sensing Insoles in Patients with Parkinson's Disease during Overground Walking in Single and Cognitive Dual-Task Conditions. SENSORS (BASEL, SWITZERLAND) 2022; 22:6392. [PMID: 36080851 PMCID: PMC9460700 DOI: 10.3390/s22176392] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Figures] [Subscribe] [Scholar Register] [Received: 06/30/2022] [Revised: 07/23/2022] [Accepted: 08/11/2022] [Indexed: 06/15/2023]
Abstract
There is a need for unobtrusive and valid tools to collect gait parameters in patients with Parkinson's disease (PD). The novel promising tools are pressure-sensing insoles connected to a smartphone app; however, few studies investigated their measurement properties during simple or challenging conditions in PD patients. This study aimed to examine the validity and reliability of gait parameters computed by pressure-sensing insoles (FeetMe® insoles, Paris, France). Twenty-five PD patients (21 males, mean age: 69 (7) years) completed two walking assessment sessions. In each session, participants walked on an electronic pressure-sensitive walkway (GaitRite®, CIR System Inc., Franklin, NJ, USA) without other additional instructions (i.e., single-task condition) and while performing a concurrent cognitive task (i.e., dual-task condition). Spatiotemporal gait parameters were measured simultaneously using the pressure-sensing insoles and the electronic walkway. Concurrent validity was assessed by correlation coefficients and Bland-Altman methodology. Test-retest reliability was examined by intraclass correlation coefficients (ICC) and minimal detectable changes (MDC). The validity results showed moderate to excellent correlations and good agreement between the two systems. Concerning test-retest reliability, moderate-to-excellent ICC values and acceptable MDC demonstrated the repeatability of the measured gait parameters. Our findings support the use of these insoles as complementary instruments to conventional tools during single and dual-task conditions.
Collapse
Affiliation(s)
- Monica Parati
- Neuroengineering and Medical Robotics Laboratory, Department of Electronics, Information and Bioengineering, Politecnico di Milano, 20133 Milan, Italy
- Istituti Clinici Scientifici Maugeri IRCCS, 20138 Milan, Italy
| | - Matteo Gallotta
- Istituti Clinici Scientifici Maugeri IRCCS, 20138 Milan, Italy
| | - Manuel Muletti
- Istituti Clinici Scientifici Maugeri IRCCS, 20138 Milan, Italy
| | - Annalisa Pirola
- Istituti Clinici Scientifici Maugeri IRCCS, 20138 Milan, Italy
| | - Alice Bellafà
- Istituti Clinici Scientifici Maugeri IRCCS, 20138 Milan, Italy
| | | | - Simona Ferrante
- Neuroengineering and Medical Robotics Laboratory, Department of Electronics, Information and Bioengineering, Politecnico di Milano, 20133 Milan, Italy
| |
Collapse
|
9
|
David R, Billot M, Ojardias E, Parratte B, Roulaud M, Ounajim A, Louis F, Meklat H, Foucault P, Lombard C, Jossart A, Mainini L, Lavallière M, Goudman L, Moens M, Laroche D, Salga M, Genêt F, Daviet JC, Perrochon A, Compagnat M, Rigoard P. A 6-Month Home-Based Functional Electrical Stimulation Program for Foot Drop in a Post-Stroke Patient: Considerations on a Time Course Analysis of Walking Performance. INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH 2022; 19:ijerph19159204. [PMID: 35954558 PMCID: PMC9367978 DOI: 10.3390/ijerph19159204] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 06/30/2022] [Revised: 07/20/2022] [Accepted: 07/23/2022] [Indexed: 12/04/2022]
Abstract
Foot drop is a common disability in post-stroke patients and represents a challenge for the clinician. To date, ankle foot orthosis (AFO) combined with conventional rehabilitation is the gold standard of rehabilitation management. AFO has a palliative mechanical action without actively restoring the associated neural function. Functional electrical stimulation (FES), consisting of stimulation of the peroneal nerve pathway, represents an alternative approach. By providing an FES device (Bioness L-300, BIONESS, Valencia, CA, USA) for 6 months to a post-stroke 22-year-old woman with a foot drop, our goal was to quantify its potential benefit on walking capacity. The gait parameters and the temporal evolution of the speed were collected with a specific connected sole device (Feet Me®) during the 10-m walking, the time up and go, and the 6-minute walking tests with AFO, FES, or without any device (NO). As a result, the walking speed changes on 10-m were clinically significant with an increase from the baseline to 6 months in AFO (+0.14 m.s−1), FES (+0.36 m.s−1) and NO (+0.32 m.s−1) conditions. In addition, the speed decreased at about 4-min in the 6-minute walking test in NO and AFO conditions, while the speed increased in the FES conditions at baseline and after 1, 3, and 6 months. In addition to the walking performance improvement, monitoring the gait speed in an endurance test after an ecological rehabilitation training program helps to examine the walking performance in post-stroke patients and to propose a specific rehabilitation program.
Collapse
Affiliation(s)
- Romain David
- PRISMATICS Lab (Predictive Research in Spine/Neuromodulation Management and Thoracic Innovation/Cardiac Surgery), Poitiers University Hospital, 86000 Poitiers, France; (R.D.); (B.P.); (M.R.); (A.O.); (P.R.)
- Department of Physical and Rehabilitation Medicine, Poitiers University Hospital, 86000 Poitiers, France; (A.J.); (L.M.)
| | - Maxime Billot
- PRISMATICS Lab (Predictive Research in Spine/Neuromodulation Management and Thoracic Innovation/Cardiac Surgery), Poitiers University Hospital, 86000 Poitiers, France; (R.D.); (B.P.); (M.R.); (A.O.); (P.R.)
- Correspondence: ; Tel.: +33-05-49-44-43-24
| | - Etienne Ojardias
- Physical Medicine and Rehabilitation Department, University Hospital of Saint-Etienne, 42270 Saint-Etienne, France;
| | - Bernard Parratte
- PRISMATICS Lab (Predictive Research in Spine/Neuromodulation Management and Thoracic Innovation/Cardiac Surgery), Poitiers University Hospital, 86000 Poitiers, France; (R.D.); (B.P.); (M.R.); (A.O.); (P.R.)
| | - Manuel Roulaud
- PRISMATICS Lab (Predictive Research in Spine/Neuromodulation Management and Thoracic Innovation/Cardiac Surgery), Poitiers University Hospital, 86000 Poitiers, France; (R.D.); (B.P.); (M.R.); (A.O.); (P.R.)
| | - Amine Ounajim
- PRISMATICS Lab (Predictive Research in Spine/Neuromodulation Management and Thoracic Innovation/Cardiac Surgery), Poitiers University Hospital, 86000 Poitiers, France; (R.D.); (B.P.); (M.R.); (A.O.); (P.R.)
| | - Frédéric Louis
- Department of Physical and Rehabilitation Medicine le Grand Feu, Rue de la Verrerie, 79000 Niort, France;
| | - Hachemi Meklat
- Department of Physical and Rehabilitation Medicine Richelieu, Rue Philippe-Vincent, 17028 La Rochelle, France; (H.M.); (P.F.); (C.L.)
| | - Philippe Foucault
- Department of Physical and Rehabilitation Medicine Richelieu, Rue Philippe-Vincent, 17028 La Rochelle, France; (H.M.); (P.F.); (C.L.)
| | - Christophe Lombard
- Department of Physical and Rehabilitation Medicine Richelieu, Rue Philippe-Vincent, 17028 La Rochelle, France; (H.M.); (P.F.); (C.L.)
| | - Anne Jossart
- Department of Physical and Rehabilitation Medicine, Poitiers University Hospital, 86000 Poitiers, France; (A.J.); (L.M.)
| | - Laura Mainini
- Department of Physical and Rehabilitation Medicine, Poitiers University Hospital, 86000 Poitiers, France; (A.J.); (L.M.)
| | - Martin Lavallière
- Module de Kinésiologie, Département des Sciences de la Santé, CISD, & Lab BioNR, Université du Québec à Chicoutimi, Chicoutimi, QC G7H 2B1, Canada;
| | - Lisa Goudman
- Department of Neurosurgery, Universitair Ziekenhuis Brussel, Laarbeeklaan 101, 1090 Brussels, Belgium; (L.G.); (M.M.)
- STIMULUS Consortium (reSearch and TeachIng neuroModULation Uz bruSsel), Vrije Universiteit Brussel, Laarbeeklaan 103, 1090 Brussels, Belgium
- Research Foundation—Flanders (FWO), 1090 Brussels, Belgium
| | - Maarten Moens
- Department of Neurosurgery, Universitair Ziekenhuis Brussel, Laarbeeklaan 101, 1090 Brussels, Belgium; (L.G.); (M.M.)
- STIMULUS Consortium (reSearch and TeachIng neuroModULation Uz bruSsel), Vrije Universiteit Brussel, Laarbeeklaan 103, 1090 Brussels, Belgium
- Department of Radiology, Universitair Ziekenhuis Brussel, Laarbeeklaan 101, 1090 Brussels, Belgium
| | - Davy Laroche
- INSERM UMR1093 Cognition, Action and Sensorimotor Plasticity Research Unit, UFR des Sciences du Sport, Université Bourgogne Franche-Comté, 21078 Dijon, France;
- INSERM, Centre d’Investigation Clinique 1432, Module Plurithematique, Plateforme d’Investigation Technologique, CHU Dijon-Bourgogne, Centre d’Investigation Clinique, Module Plurithématique, Plateforme d’Investigation Technologique, 21079 Dijon, France
| | - Marjorie Salga
- UPOH (Unité Péri Opératoire du Handicap, Perioperative Disability Unit), Physical and Rehabilitation Medicine Department, Raymond-Poincaré Hospital, Assistance Publique—Hôpitaux de Paris (AP-HP), 92380 Garches, France; (M.S.); (F.G.)
- Inserm U1179, END-ICAP (Handicap neuromusculaire: Physiopathologie, Biothérapie et Pharmacologie Appliquées), UFR Simone Veil—Santé, Versailles Saint-Quentin-en-Yvelines University (UVSQ), 78180 Montigny-le-Bretonneux, France
| | - François Genêt
- UPOH (Unité Péri Opératoire du Handicap, Perioperative Disability Unit), Physical and Rehabilitation Medicine Department, Raymond-Poincaré Hospital, Assistance Publique—Hôpitaux de Paris (AP-HP), 92380 Garches, France; (M.S.); (F.G.)
- Inserm U1179, END-ICAP (Handicap neuromusculaire: Physiopathologie, Biothérapie et Pharmacologie Appliquées), UFR Simone Veil—Santé, Versailles Saint-Quentin-en-Yvelines University (UVSQ), 78180 Montigny-le-Bretonneux, France
| | - Jean-Christophe Daviet
- HAVAE UR20217 (Handicap, Ageing, Autonomy, Environment), University of Limoges, 87000 Limoges, France; (J.-C.D.); (A.P.); (M.C.)
- Department of Physical Medicine and Rehabilitation, University Hospital Center of Limoges, 87000 Limoges, France
| | - Anaick Perrochon
- HAVAE UR20217 (Handicap, Ageing, Autonomy, Environment), University of Limoges, 87000 Limoges, France; (J.-C.D.); (A.P.); (M.C.)
| | - Maxence Compagnat
- HAVAE UR20217 (Handicap, Ageing, Autonomy, Environment), University of Limoges, 87000 Limoges, France; (J.-C.D.); (A.P.); (M.C.)
- Department of Physical Medicine and Rehabilitation, University Hospital Center of Limoges, 87000 Limoges, France
| | - Philippe Rigoard
- PRISMATICS Lab (Predictive Research in Spine/Neuromodulation Management and Thoracic Innovation/Cardiac Surgery), Poitiers University Hospital, 86000 Poitiers, France; (R.D.); (B.P.); (M.R.); (A.O.); (P.R.)
- Department of Neuro-Spine & Neuromodulation, Poitiers University Hospital, 86000 Poitiers, France
- Prime Institute UPR 3346, CNRS, ISAE-ENSMA (Institut Supérieur de l’Aéronautique et de l’Espace—École Nationale Supérieure de Mécanique et d’Aérotechnique Poitiers Futuroscope), University of Poitiers, 86000 Poitiers, France
| |
Collapse
|
10
|
Salchow-Hömmen C, Skrobot M, Jochner MCE, Schauer T, Kühn AA, Wenger N. Review-Emerging Portable Technologies for Gait Analysis in Neurological Disorders. Front Hum Neurosci 2022; 16:768575. [PMID: 35185496 PMCID: PMC8850274 DOI: 10.3389/fnhum.2022.768575] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/31/2021] [Accepted: 01/07/2022] [Indexed: 01/29/2023] Open
Abstract
The understanding of locomotion in neurological disorders requires technologies for quantitative gait analysis. Numerous modalities are available today to objectively capture spatiotemporal gait and postural control features. Nevertheless, many obstacles prevent the application of these technologies to their full potential in neurological research and especially clinical practice. These include the required expert knowledge, time for data collection, and missing standards for data analysis and reporting. Here, we provide a technological review of wearable and vision-based portable motion analysis tools that emerged in the last decade with recent applications in neurological disorders such as Parkinson's disease and Multiple Sclerosis. The goal is to enable the reader to understand the available technologies with their individual strengths and limitations in order to make an informed decision for own investigations and clinical applications. We foresee that ongoing developments toward user-friendly automated devices will allow for closed-loop applications, long-term monitoring, and telemedical consulting in real-life environments.
Collapse
Affiliation(s)
- Christina Salchow-Hömmen
- Department of Neurology With Experimental Neurology, Charité-Universitätsmedizin Berlin, Berlin, Germany
| | - Matej Skrobot
- Department of Neurology With Experimental Neurology, Charité-Universitätsmedizin Berlin, Berlin, Germany
| | - Magdalena C E Jochner
- Department of Neurology With Experimental Neurology, Charité-Universitätsmedizin Berlin, Berlin, Germany
| | - Thomas Schauer
- Control Systems Group, Technische Universität Berlin, Berlin, Germany
| | - Andrea A Kühn
- Department of Neurology With Experimental Neurology, Charité-Universitätsmedizin Berlin, Berlin, Germany
- Berlin School of Mind and Brain, Charité-Universitätsmedizin Berlin, Berlin, Germany
- NeuroCure Clinical Research Centre, Charité-Universitätsmedizin Berlin, Berlin, Germany
- German Center for Neurodegenerative Diseases, DZNE, Berlin, Germany
| | - Nikolaus Wenger
- Department of Neurology With Experimental Neurology, Charité-Universitätsmedizin Berlin, Berlin, Germany
| |
Collapse
|
11
|
Felius RAW, Geerars M, Bruijn SM, van Dieën JH, Wouda NC, Punt M. Reliability of IMU-Based Gait Assessment in Clinical Stroke Rehabilitation. SENSORS 2022; 22:s22030908. [PMID: 35161654 PMCID: PMC8839370 DOI: 10.3390/s22030908] [Citation(s) in RCA: 10] [Impact Index Per Article: 5.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 12/17/2021] [Revised: 01/16/2022] [Accepted: 01/19/2022] [Indexed: 02/06/2023]
Abstract
Background: Gait is often impaired in people after stroke, restricting personal independence and affecting quality of life. During stroke rehabilitation, walking capacity is conventionally assessed by measuring walking distance and speed. Gait features, such as asymmetry and variability, are not routinely determined, but may provide more specific insights into the patient’s walking capacity. Inertial measurement units offer a feasible and promising tool to determine these gait features. Objective: We examined the test–retest reliability of inertial measurement units-based gait features measured in a two-minute walking assessment in people after stroke and while in clinical rehabilitation. Method: Thirty-one people after stroke performed two assessments with a test–retest interval of 24 h. Each assessment consisted of a two-minute walking test on a 14-m walking path. Participants were equipped with three inertial measurement units, placed at both feet and at the low back. In total, 166 gait features were calculated for each assessment, consisting of spatio-temporal (56), frequency (26), complexity (63), and asymmetry (14) features. The reliability was determined using the intraclass correlation coefficient. Additionally, the minimal detectable change and the relative minimal detectable change were computed. Results: Overall, 107 gait features had good–excellent reliability, consisting of 50 spatio-temporal, 8 frequency, 36 complexity, and 13 symmetry features. The relative minimal detectable change of these features ranged between 0.5 and 1.5 standard deviations. Conclusion: Gait can reliably be assessed in people after stroke in clinical stroke rehabilitation using three inertial measurement units.
Collapse
Affiliation(s)
- Richard A. W. Felius
- Research Group Lifestyle and Health, Utrecht University of Applied Sciences, 3584 CS Utrecht, The Netherlands; (M.G.); (N.C.W.); (M.P.)
- Faculty of Human Movement Sciences, Vrije Universiteit Amsterdam, 1081 HV Amsterdam, The Netherlands; (S.M.B.); (J.H.v.D.)
- Correspondence:
| | - Marieke Geerars
- Research Group Lifestyle and Health, Utrecht University of Applied Sciences, 3584 CS Utrecht, The Netherlands; (M.G.); (N.C.W.); (M.P.)
- Physiotherapy Department Neurology, Rehabilitation Center de Parkgraaf, 3526 KJ Utrecht, The Netherlands
| | - Sjoerd M. Bruijn
- Faculty of Human Movement Sciences, Vrije Universiteit Amsterdam, 1081 HV Amsterdam, The Netherlands; (S.M.B.); (J.H.v.D.)
| | - Jaap H. van Dieën
- Faculty of Human Movement Sciences, Vrije Universiteit Amsterdam, 1081 HV Amsterdam, The Netherlands; (S.M.B.); (J.H.v.D.)
| | - Natasja C. Wouda
- Research Group Lifestyle and Health, Utrecht University of Applied Sciences, 3584 CS Utrecht, The Netherlands; (M.G.); (N.C.W.); (M.P.)
- Physiotherapy Department Neurology, De Hoogstraat Revalidatie, 3583 TM Utrecht, The Netherlands
| | - Michiel Punt
- Research Group Lifestyle and Health, Utrecht University of Applied Sciences, 3584 CS Utrecht, The Netherlands; (M.G.); (N.C.W.); (M.P.)
| |
Collapse
|
12
|
Subramaniam S, Majumder S, Faisal AI, Deen MJ. Insole-Based Systems for Health Monitoring: Current Solutions and Research Challenges. SENSORS (BASEL, SWITZERLAND) 2022; 22:438. [PMID: 35062398 PMCID: PMC8780030 DOI: 10.3390/s22020438] [Citation(s) in RCA: 19] [Impact Index Per Article: 9.5] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 12/11/2021] [Revised: 01/01/2022] [Accepted: 01/03/2022] [Indexed: 02/04/2023]
Abstract
Wearable health monitoring devices allow for measuring physiological parameters without restricting individuals' daily activities, providing information that is reflective of an individual's health and well-being. However, these systems need to be accurate, power-efficient, unobtrusive and simple to use to enable a reliable, convenient, automatic and ubiquitous means of long-term health monitoring. One such system can be embedded in an insole to obtain physiological data from the plantar aspect of the foot that can be analyzed to gain insight into an individual's health. This manuscript provides a comprehensive review of insole-based sensor systems that measure a variety of parameters useful for overall health monitoring, with a focus on insole-based PPD measurement systems developed in recent years. Existing solutions are reviewed, and several open issues are presented and discussed. The concept of a fully integrated insole-based health monitoring system and considerations for future work are described. By developing a system that is capable of measuring parameters such as PPD, gait characteristics, foot temperature and heart rate, a holistic understanding of an individual's health and well-being can be obtained without interrupting day-to-day activities. The proposed device can have a multitude of applications, such as for pathology detection, tracking medical conditions and analyzing gait characteristics.
Collapse
Affiliation(s)
- Sophini Subramaniam
- School of Biomedical Engineering, McMaster University, Hamilton, ON L8S 4L8, Canada;
| | - Sumit Majumder
- Electrical and Computer Engineering, McMaster University, Hamilton, ON L8S 4L8, Canada; (S.M.); (A.I.F.)
- Department of Biomedical Engineering, Chittagong University of Engineering and Technology, Chattogram 4349, Bangladesh
| | - Abu Ilius Faisal
- Electrical and Computer Engineering, McMaster University, Hamilton, ON L8S 4L8, Canada; (S.M.); (A.I.F.)
| | - M. Jamal Deen
- School of Biomedical Engineering, McMaster University, Hamilton, ON L8S 4L8, Canada;
- Electrical and Computer Engineering, McMaster University, Hamilton, ON L8S 4L8, Canada; (S.M.); (A.I.F.)
| |
Collapse
|
13
|
Test-Retest Reliability of PODOSmart ® Gait Analysis Insoles. SENSORS 2021; 21:s21227532. [PMID: 34833607 PMCID: PMC8619744 DOI: 10.3390/s21227532] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 10/18/2021] [Revised: 11/04/2021] [Accepted: 11/11/2021] [Indexed: 12/20/2022]
Abstract
It is recognized that gait analysis is a powerful tool used to capture human locomotion and quantify the related parameters. PODOSmart® insoles have been designed to provide accurate measurements for gait analysis. PODOSmart® insoles are lightweight, slim and cost-effective. A recent publication presented the characteristics and data concerning the validity of PODOSmart® insoles in gait analysis. In literature, there is still no evidence about the repeatability of PODOSmart® gait analysis system. Such evidence is essential in order to use this device in both research and clinical settings. The aim of the present study was to assess the repeatability of PODOSmart® system. In this context, it was hypothesized that the parameters of gait analysis captured by PODOSmart® would be repeatable. In a sample consisting of 22 healthy male adults, participants performed two walking trials on a six-meter walkway. The ICC values for 28 gait variables provided by PODOSmart® indicated good to excellent test-retest reliability, ranging from 0.802 to 0.997. The present findings confirm that PODOSmart® gait analysis insoles present excellent repeatability in gait analysis parameters. These results offer additional evidence regarding the reliability of this gait analysis tool.
Collapse
|
14
|
The Effects of Auditory Feedback Gait Training Using Smart Insole on Stroke Patients. Brain Sci 2021; 11:brainsci11111377. [PMID: 34827376 PMCID: PMC8615866 DOI: 10.3390/brainsci11111377] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/19/2021] [Revised: 10/12/2021] [Accepted: 10/19/2021] [Indexed: 12/02/2022] Open
Abstract
This study aimed to assess the effect of the auditory feedback gait training (AFGT) using smart insole on the gait variables, dynamic balance, and activities of daily living (ADL) of stroke patients. In this case, 45 chronic stroke patients who were diagnosed with a stroke before 6 months and could walk more than 10 m were included in this study. Participants were randomly allocated to the smart insole training group (n = 23), in which the AFGT system was used, or to the general gait training group (GGTG) (n = 22). Both groups completed conventional rehabilitation, including conventional physiotherapy and gait training, lasting 60 min per session, five times per week for 4 weeks. Instead of gait training, the smart insole training group received smart insole training twice per week for 4 weeks. Participants were assessed using the GAITRite for gait variables and Timed Up and Go test (TUG), Berg Balance Scale (BBS) for dynamic balance, and Modified Barthel Index (MBI) for ADL. The spatiotemporal gait parameters, symmetry of gait, TUG, BBS, and MBI in the smart insole training group were significantly improved compared to those in the GGTG (p < 0.05). The AFGT system approach is a helpful method for improving gait variables, dynamic balance, and ADL in chronic stroke patients.
Collapse
|
15
|
Jacobs D, Farid L, Ferré S, Herraez K, Gracies JM, Hutin E. Evaluation of the Validity and Reliability of Connected Insoles to Measure Gait Parameters in Healthy Adults. SENSORS 2021; 21:s21196543. [PMID: 34640868 PMCID: PMC8512009 DOI: 10.3390/s21196543] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 08/30/2021] [Revised: 09/21/2021] [Accepted: 09/23/2021] [Indexed: 11/16/2022]
Abstract
The continuous, accurate and reliable estimation of gait parameters as a measure of mobility is essential to assess the loss of functional capacity related to the progression of disease. Connected insoles are suitable wearable devices which allow precise, continuous, remote and passive gait assessment. The data of 25 healthy volunteers aged 20 to 77 years were analysed in the study to validate gait parameters (stride length, velocity, stance, swing, step and single support durations and cadence) measured by FeetMe® insoles against the GAITRite® mat reference. The mean values and the values of variability were calculated per subject for GAITRite® and insoles. A t-test and Levene’s test were used to compare the gait parameters for means and variances, respectively, obtained for both devices. Additionally, measures of bias, standard deviation of differences, Pearson’s correlation and intraclass correlation were analysed to explore overall agreement between the two devices. No significant differences in mean and variance between the two devices were detected. Pearson’s correlation coefficients of averaged gait estimates were higher than 0.98 and 0.8, respectively, for unipedal and bipedal gait parameters, supporting a high level of agreement between the two devices. The connected insoles are therefore a device equivalent to GAITRite® to estimate the mean and variability of gait parameters.
Collapse
Affiliation(s)
- Damien Jacobs
- FeetMe S.A.S., 157 bd. MacDonald, 75019 Paris, France; (L.F.); (S.F.)
- Correspondence:
| | - Leila Farid
- FeetMe S.A.S., 157 bd. MacDonald, 75019 Paris, France; (L.F.); (S.F.)
| | - Sabine Ferré
- FeetMe S.A.S., 157 bd. MacDonald, 75019 Paris, France; (L.F.); (S.F.)
| | - Kilian Herraez
- UFR de Mathématiques, Université Pierre et Marie Curie, 75005 Paris, France;
| | - Jean-Michel Gracies
- Laboratoire Analyse et Restauration du Mouvement (ARM), Hôpitaux Universitaires Henri Mondor, Assistance Publique des Hôpitaux de Paris (AP-HP), 94000 Créteil, France; (J.-M.G.); (E.H.)
- EA 7377 Bioingénierie, Tissus et Neuroplasticité (BIOTN), Université Paris-Est Créteil (UPEC), 94000 Créteil, France
| | - Emilie Hutin
- Laboratoire Analyse et Restauration du Mouvement (ARM), Hôpitaux Universitaires Henri Mondor, Assistance Publique des Hôpitaux de Paris (AP-HP), 94000 Créteil, France; (J.-M.G.); (E.H.)
- EA 7377 Bioingénierie, Tissus et Neuroplasticité (BIOTN), Université Paris-Est Créteil (UPEC), 94000 Créteil, France
| |
Collapse
|
16
|
MejiaCruz Y, Franco J, Hainline G, Fritz S, Jiang Z, Caicedo JM, Davis B, Hirth V. Walking speed measurement technology: A review. CURRENT GERIATRICS REPORTS 2021; 10:32-41. [PMID: 33816062 DOI: 10.1007/s13670-020-00349-z] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
Abstract
Purpose of review This article presents an overview of the main technologies used to estimate gait parameters, focusing on walking speed (WS). Recent findings New wearable and environmental technologies to estimate WS have been developed in the last five years. Wearable technologies refer to sensors attached to parts of the patient's body that capture the kinematics during walking. Alternatively, environmental technologies capture walking patterns using external instrumentation. In this review, wearable and external technologies have been included.From the different works reviewed, external technologies face the challenge of implementation outside controlled facilities; an advantage that wearable technologies have, but have not been fully explored. Additionally, systems that can track WS changes in daily activities, especially at-home assessments, have not been developed. Summary Walking speed is a gait parameter that can provide insight into an individual's health status. Image-based, walkways, wearable, and floor-vibrations technologies are the most current used technologies for estimating WS. In this paper, research from the last five years that explore each technology's capabilities on WS estimation and an evaluation of their technical and clinical aspects is presented.
Collapse
Affiliation(s)
- Yohanna MejiaCruz
- San Francisco State University, 1600 Holloway Ave, San Francisco, CA 94132
| | - Jean Franco
- University of South Carolina, 300 Main St, Columbia SC, 29201
| | - Garret Hainline
- University of South Carolina, 300 Main St, Columbia SC, 29201
| | - Stacy Fritz
- University of South Carolina, 300 Main St, Columbia SC, 29201
| | - Zhaoshuo Jiang
- San Francisco State University, 1600 Holloway Ave, San Francisco, CA 94132
| | - Juan M Caicedo
- University of South Carolina, 300 Main St, Columbia SC, 29201
| | - Benjamin Davis
- Advanced Smart Systems and Evaluation Technologies (ASSET), LLC, 1400 Laurel Street, Suite 1B, Columbia, South Carolina 29201
| | - Victor Hirth
- Geriatric Health and Wellness, LTD, One Still Hopes Drive, West Columbia, SC 29169
| |
Collapse
|